64
Views
12
CrossRef citations to date
0
Altmetric
Original Article

A new aqueous dithranol gel for psoriasis: Comparison with placebo and calcipotriol ointment

, &
Pages 11-15 | Received 07 May 1996, Accepted 02 Dec 1996, Published online: 12 Jul 2009

References

  • Greaves M W, Weinstein G D. Treatment of psoriasis. N Engl J Med 1995; 332: 581–8
  • Galewsky E. Ueber Cignolin ein Ersatzpraparat des Chrysarobins. Dermatol Wchnschr 1916; 62: 113–15
  • Unna P G. Cignolin als Heilmittel der Psoriasis. Dermatol Wchnschr 1916; 62: 116–37, 151–63, 175–83
  • Ingram J T. The approach to psoriasis. BMJ 1953; 2: 591–4
  • Seville R H. Simplified dithranol treatment of psoriasis. Br I Dermatol 1975; 93: 205–8
  • Seville R H, Walker G B, Whitefield M. Dithranol cream. Br I Dermatol 1979; 100: 475–6
  • Schaefer H, Farber E M, Goldberg L, et al. Limited application period for dithranol in psoriasis: preliminary report on penetration and clinical efficacy. Br I Dermatol 1980; 102: 571–3
  • Berth-Jones J, Chu A C, Dodd W AH, et al. A multicentre, parallel-group comparison of calcipotriol ointment and short-contact dithranol therapy in chronic plaque psoriasis. Br I Dermatol 1992; 127: 266–71
  • Cunliffe W J, Berth-Jones J, Claudy A, et al. Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris. J Am Acad Dermatol 1992; 26: 736–43

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.